Archivos de cardiologia de Mexico最新文献_第8页

Left ventricular hypertrophy: hypertensive or hypertrophic cardiomyopathy? What a dilemma! A case report. 左心室肥厚：高血压还是肥厚性心肌病？真是进退两难！病例报告。

Archivos de cardiologia de Mexico Pub Date : 2024-02-08 DOI: 10.24875/ACM.23000063

Albina Aldomà-Balasch, Marta Z Zielonka, Pedro K Rivera-Aguilar, Ramón Bascompte-Claret

{"title":"Left ventricular hypertrophy: hypertensive or hypertrophic cardiomyopathy? What a dilemma! A case report.","authors":"Albina Aldomà-Balasch, Marta Z Zielonka, Pedro K Rivera-Aguilar, Ramón Bascompte-Claret","doi":"10.24875/ACM.23000063","DOIUrl":"10.24875/ACM.23000063","url":null,"abstract":"In the presence of the left ventricle hypertrophy (LVH), the differential diagnosis with hypertrophic cardiomyopathy (HCM) or some phenocopy must be always considered, which can be easily suspected when the hypertrophy is markedly asymmetric. However, when the hypertrophy is homogeneous, especially if the patient has concomitant hypertension, it may be a challenge to distinguish between hypertensive and HCM, although some clinical features may help us to suspect it. In addition, patients with HCM may present with exertional angina due to microcirculation involvement in the setting of the hypertrophy itself or dynamic obstruction in the left ventricular outflow tract, but in some cases, the presence of concomitant coronary artery disease must be suspected as the cause of angina, especially if the patient has an intermediate or high-risk probability of having ischemic heart disease. We present the case of a 46-year-old Afro-American man with poorly controlled hypertension who was found to have severe LVH, and who presented with symptoms of exertional angina during follow-up. We will review the clinical features that can help us in the differential diagnosis in this context.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"203-207"},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139708741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Phosphodiesterase 5 inhibitors for the treatment of heart failure: a systematic review and meta-analysis]. [治疗心力衰竭的磷酸二酯酶 5 抑制剂：系统回顾和荟萃分析]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-08 DOI: 10.24875/ACM.23000209

Ramiro Monzón-Herrera, Federico Listorti, Natalia Vensentini, Javier Mariani

{"title":"[Phosphodiesterase 5 inhibitors for the treatment of heart failure: a systematic review and meta-analysis].","authors":"Ramiro Monzón-Herrera, Federico Listorti, Natalia Vensentini, Javier Mariani","doi":"10.24875/ACM.23000209","DOIUrl":"10.24875/ACM.23000209","url":null,"abstract":"Objective: The treatment with phosphodiesterase-5 (PDE-5) inhibitors was postulated in heart failure (HF). We conducted a systematic review and a meta-analysis on their beneficial and adverse effects in patients with HF.Method: A meta-analysis of randomized trials evaluating the chronic use of PDE-5 inhibitors in patients with HF was conducted. Endpoints included death, HF hospitalizations, functional capacity, pulmonary pressures, quality of life, and adverse effects. Random-effects models were used to pool outcomes. Categorical data were summarized with relative risks (RR) and 95% confidence intervals (95%CI), and continuous data with weighted mean differences and standardized mean differences.Results: Sixteen studies (1119 participants) were included. No effect was observed on mortality (RR: 1.16; 95%CI: 0.50-2.66; I2: 0.0%) or HF hospitalizations (RR: 0.75; 95%CI: 0.41-1.37; I2: 38.7%). Treatment significantly reduced pulmonary systolic pressure (-10.64 mmHg; 95%CI: -5.14 to -16.15 mmHg; I2: 96.0%), and increased peak oxygen consumption (2.06 ml/kg/min; 95%CI: 0.40-3.72; I2: 89.6%), although with high inconsistency. There were no significant effects on quality of life (-0.15; 95%CI: -0.48-0.18; I2: 0.0%). On the other hand, the risk of headaches was increased (RR: 1.63; 95%CI: 1.11-2.39; I2: 0.0%). Publication bias was identified for HF hospitalizations.Conclusions: Current data suggest that PDE-5 inhibitors therapy does not improve prognosis or quality of life among HF patients. Hemodynamic and functional effects could be relevant, and more studies are necessary to define its role.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"309-323"},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139708740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Increased risk of bleeding in patients with atrial fibrillation and chronic kidney disease on hemodialysis treated with anticoagulants. A four center serie]. [使用抗凝剂进行血液透析的心房颤动和慢性肾病患者的出血风险增加。四个中心的研究]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-07 DOI: 10.24875/ACM.23000006

Laura V López-Gutiérrez, María I Mora-Atehortúa, Sebastián Peláez-García, Fabián A Jaimes-Barragán, Yesid A Saavedra-González, Diego A Ossa-Estrada, Juan P Villegas-Molina, Andrés H Polo-Guzmán, Clara I Saldarriaga-Giraldo

{"title":"[Increased risk of bleeding in patients with atrial fibrillation and chronic kidney disease on hemodialysis treated with anticoagulants. A four center serie].","authors":"Laura V López-Gutiérrez, María I Mora-Atehortúa, Sebastián Peláez-García, Fabián A Jaimes-Barragán, Yesid A Saavedra-González, Diego A Ossa-Estrada, Juan P Villegas-Molina, Andrés H Polo-Guzmán, Clara I Saldarriaga-Giraldo","doi":"10.24875/ACM.23000006","DOIUrl":"10.24875/ACM.23000006","url":null,"abstract":"Background: Because the benefits and risks of anticoagulation are still unknown in patients with atrial fibrillation (AF) and with chronic kidney disease (CKD) on hemodialysis.Objective: The aim of this study was to estimate whether the consumption of anticoagulants was associated with a difference in the frequency of thrombosis of any site, major bleeding and mortality, in adults with both diseases.Method: A retrospective cohort study was carried out in four high complexity centers. Patients older than 18 years with CKD on hemodialysis and non-valvular AF, with an indication for anticoagulation (CHA2DS-2VASc ≥ 2), were included. The primary outcome was the occurrence of: major bleeding, thrombotic event (cerebrovascular accident, acute myocardial infarction or venous thromboembolic disease) or death. Adjustment for confounding variables was performed using logistic regression.Results: From 158 patients included, 61% (n = 97) received an anticoagulant. The main outcome was found in 84% of those who received anticoagulation and 70% of those who did not (OR: 2.12, 95%CI: 0.98-4.57; after the adjusted analysis OR: 2.13, 95%CI: 1.04-4.36). Separate outcomes were bleeding in 52% vs. 34% (OR: 2.03; 95%CI: 1.05-3.93), thrombosis in 35% vs. 34% (OR: 1.03; 95%CI: 0.52-2-01) and death in 46% vs 41% (OR: 1.25; 95%CI: 0.65-2.38).Conclusions: The results of this study suggest an increased risk of bleeding in patients with AF and CKD on hemodialysis receiving anticoagulation, without a decrease in the risk of thrombotic events or all-cause mortality.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"151-160"},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139704240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes]. [摘要：关于先天性双尖瓣及其主动脉病变的命名和分类的国际共识声明，用于临床、手术、介入和研究目的]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-07 DOI: 10.24875/ACM.24000002

Hector I Michelena, Alessandro Della Corte, Arturo Evangelista, Joseph J Maleszewski, William D Edwards, Mary J Roman, Richard B Devereux, Borja Fernández, Federico M Asch, Alex J Barker, Lilia M Sierra, Laurent de Kerchove, Susan M Fernandes, Paul W M Fedak, Evaldas Girdauskas, Victoria Delgado, Suhny Abbara, Emmanuel Lansac, Siddharth K Prakash, Malenka M Bissell, Bogdan A Popescu, Michael D Hope, Marta Sitges, Vinod H Thourani, Phillippe Pibarot, Krishnaswamy Chandrasekaran, Patrizio Lancellotti, Michael A Borger, John K Forrest, John Webb, Dianna M Milewicz, Raj Makkar, Martin B Leon, Stephen P Sanders, Michael Markl, Victor A Ferrari, William C Roberts, Jae-Kwan Song, Philipp Blanke, Charles S White, Samuel Siu, Lars G Svensson, Alan C Braverman, Joseph Bavaria, Thoralf M Sundt, Gebrine El Khoury, Ruggero de Paulis, Maurice Enriquez-Sarano, Jeroen J Bax, Catherine M Otto, Hans-Joachim Schäfers

{"title":"[Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes].","authors":"Hector I Michelena, Alessandro Della Corte, Arturo Evangelista, Joseph J Maleszewski, William D Edwards, Mary J Roman, Richard B Devereux, Borja Fernández, Federico M Asch, Alex J Barker, Lilia M Sierra, Laurent de Kerchove, Susan M Fernandes, Paul W M Fedak, Evaldas Girdauskas, Victoria Delgado, Suhny Abbara, Emmanuel Lansac, Siddharth K Prakash, Malenka M Bissell, Bogdan A Popescu, Michael D Hope, Marta Sitges, Vinod H Thourani, Phillippe Pibarot, Krishnaswamy Chandrasekaran, Patrizio Lancellotti, Michael A Borger, John K Forrest, John Webb, Dianna M Milewicz, Raj Makkar, Martin B Leon, Stephen P Sanders, Michael Markl, Victor A Ferrari, William C Roberts, Jae-Kwan Song, Philipp Blanke, Charles S White, Samuel Siu, Lars G Svensson, Alan C Braverman, Joseph Bavaria, Thoralf M Sundt, Gebrine El Khoury, Ruggero de Paulis, Maurice Enriquez-Sarano, Jeroen J Bax, Catherine M Otto, Hans-Joachim Schäfers","doi":"10.24875/ACM.24000002","DOIUrl":"10.24875/ACM.24000002","url":null,"abstract":"This consensus of nomenclature and classification for congenital bicuspid aortic valve and its aortopathy is evidence-based and intended for universal use by physicians (both pediatricians and adults), echocardiographers, advanced cardiovascular imaging specialists, interventional cardiologists, cardiovascular surgeons, pathologists, geneticists, and researchers spanning these areas of clinical and basic research. In addition, as long as new key and reference research is available, this international consensus may be subject to change based on evidence-based data1.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"219-239"},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139704241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Multiple pulmonary aneurysms and infective endocarditis as initial presentation of persistent ductus arteriosus. 多发性肺动脉瘤和感染性心内膜炎是持续性动脉导管未闭的最初表现。

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000058

David J Sánchez-Amaya, Mateo D Gutiérrez-Castañeda, Diego Araiza-Garaygordobil, Alexandra Arias-Mendoza

引用次数: 0

Out of hospital cardiac arrest, first steps to know and follow in Mexico to have cardioprotected territories. A point of view of a group of experts. 院外心脏骤停，墨西哥心脏保护领域需要了解和遵循的首要步骤。专家组的观点。

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000072

Jorge Álvarez de la Cadena-Sillas, Enrique Asensio-Lafuente, David Martínez-Dunker, Agustín Urzúa-Gonzalez, Manuel Celaya-Cota, Luisa F Aguilera-Mora, José Lainez-Zelaya, Lillian Hernández-Garcia, Erik H González-Cruz

{"title":"Out of hospital cardiac arrest, first steps to know and follow in Mexico to have cardioprotected territories. A point of view of a group of experts.","authors":"Jorge Álvarez de la Cadena-Sillas, Enrique Asensio-Lafuente, David Martínez-Dunker, Agustín Urzúa-Gonzalez, Manuel Celaya-Cota, Luisa F Aguilera-Mora, José Lainez-Zelaya, Lillian Hernández-Garcia, Erik H González-Cruz","doi":"10.24875/ACM.23000072","DOIUrl":"10.24875/ACM.23000072","url":null,"abstract":"Sudden cardiac death is a common occurrence. Out-of-hospital cardiac arrest is a global public health problem suffered by ≈3.8 million people annually. Progress has been made in the knowledge of this disease, its prevention, and treatment; however, most events occur in people without a previous diagnosis of heart disease. Due to its multifactorial and complex nature, it represents a challenge in public health, so it led us to work in a consensus to achieve the implementation of cardioprotected areas in Mexico as a priority mechanism to treat these events. Public access cardiopulmonary resuscitation (CPR) and early defibrillation require training of non-medical personnel, who are usually the first responders in the chain of survival. They should be able to establish a basic and efficient CPR and use of the automatic external defibrillator (AED) until the emergency services arrive at the scene of the incident. Some of the current problems in Mexico and alternative solutions for them are addressed in the present work.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"174-180"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Etiology and evolution of anemia in patients submitted to cardiovascular surgery]. [心血管手术患者贫血的病因和演变]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000090

Gonzalo M Fernández-Villar, Mauricio Delgado-Gaete, Marco A Borja-Yenchong, Emiliano Rossi, Elsa M Nucifora, Vadim Kotowicz, Rodolfo Pizarro

{"title":"[Etiology and evolution of anemia in patients submitted to cardiovascular surgery].","authors":"Gonzalo M Fernández-Villar, Mauricio Delgado-Gaete, Marco A Borja-Yenchong, Emiliano Rossi, Elsa M Nucifora, Vadim Kotowicz, Rodolfo Pizarro","doi":"10.24875/ACM.23000090","DOIUrl":"10.24875/ACM.23000090","url":null,"abstract":"Introduction: Anemia is associated with increased mortality in patients undergoing major surgeries.Objective: The aim of this study is to evaluate the prevalence of anemia in the preoperative period of cardiovascular surgery, its postoperative incidence and its evolution during the first month in our setting.Methods: A prospective cohort study was carried out in which all patients undergoing central cardiovascular surgery operated during the period 09/01/2021-09/01/2022 in a university hospital were included. Clinical and laboratory follow-up was carried out prior to surgery, on the fifth and on the 30th postoperative day. Groups with and without preoperative anemia were compared.Results: The prevalence of anemia in the preoperative period was 32.1%. The incidence of anemia in the postoperative period was 96% in the group of patients without previous anemia. One month after surgery, 73 and 90% of the patients, with and without preoperative anemia, respectively, remained anemic. Patients with preoperative anemia had less recovery of their hemoglobin values at one month. A trend towards higher mortality and a greater need for referral to post-hospital discharge rehabilitation centers was observed in those with preoperative anemia.Conclusions: In this work, a high prevalence and incidence of anemia in the perioperative period of cardiovascular surgeries was evidenced. As well as its subtreatment and high persistence during the month after surgery.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"133-140"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Correlation of left ventricular contractile function with the presence of collateral coronary circulation in non-reperfused acute myocardial infarction]. [非再灌注急性心肌梗死患者左心室收缩功能与冠状动脉侧支循环存在的相关性]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000084

Diego R Campos-Franco, Héctor González-Pacheco, Alexandra Arias-Mendoza

{"title":"[Correlation of left ventricular contractile function with the presence of collateral coronary circulation in non-reperfused acute myocardial infarction].","authors":"Diego R Campos-Franco, Héctor González-Pacheco, Alexandra Arias-Mendoza","doi":"10.24875/ACM.23000084","DOIUrl":"10.24875/ACM.23000084","url":null,"abstract":"Objective: To assess the association between coronary collateral circulation and ventricular contractile function in patients with non-reperfused acute myocardial infarction.Method: A retrospective and descriptive clinical study was conducted on patients with ST-elevation myocardial infarction (STEMI) at a reference cardiovascular center, from January 2006 to December 2022. Coronary angiographies and echocardiograms were reviewed to evaluate coronary collateral circulation and ventricular function, respectively. Patients were divided into groups based on the presence of collateral circulation. Both groups were compared and mortality during the index hospitalization was analyzed.Results: Out of a total of 14,985 patients with acute coronary syndrome, 8134 (54.3%) had the diagnosis of STEMI. We excluded 12,880, leaving a total of 2105 non-reperfused STEMI patients who underwent coronary angiography, revealing lesions. There were more patients without collateral circulation: 1547 (73.5%) vs. 558 (26.5%) (p = 0.025). Patients without collateral circulation had a higher left ventricular ejection fraction (median of 47% vs. 42%; p < 0.001). Mortality in patients with collateral circulation was higher compared to those without it (11.6% vs. 9.8%; p = 0.225), but statistical significance was not reached.Conclusions: Non-reperfused STEMI patients did not show protection from collateral circulation when assessing left ventricular systolic function. We did not find a difference in mortality compared to the population without development of collateral circulation.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"286-291"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician]. [C-反应蛋白，急性期蛋白的心血管问题：给临床医生的最新信息]。

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000032

Arturo Sáenz-San Martín, Pablo Méndez-Ocampo, Iván Gutiérrez-Moctezuma, Luis M Amezcua-Guerra

{"title":"[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician].","authors":"Arturo Sáenz-San Martín, Pablo Méndez-Ocampo, Iván Gutiérrez-Moctezuma, Luis M Amezcua-Guerra","doi":"10.24875/ACM.23000032","DOIUrl":"10.24875/ACM.23000032","url":null,"abstract":"Inflammation is an important pathogenic factor for the development of atherosclerotic cardiovascular disease. Currently, the most frequently used biomarker reflecting systemic inflammation is C-reactive protein (CRP), an acute-phase protein produced primarily by hepatocytes under the influence of interleukin-6, interleukin-1 beta, and tumor necrosis factor. Growing evidence from epidemiological studies has shown a robust association between elevated serum or plasma CRP concentrations and the incidence of a first cardiovascular adverse event (including acute myocardial infarction, ischemic stroke, and sudden cardiac death) in the general population, as well as recurrence of major adverse cardiovascular events among patients with established disease. The additive value that CRP measurement gives to traditional risk factors is reflected in novel cardiovascular risk calculators and in current intervention regimens, which already consider CRP as a target therapeutic. However, the variations in CRP levels, that depend on sex, ethnicity, hormonal status, and some peculiarities of the measurement assays, must be taken into consideration when deciding to implement CRP as a useful biomarker in the study and treatment of atherosclerotic cardiovascular disease. This review aims to offer an updated vision of the importance of measuring CRP levels as a biomarker of cardiovascular risk beyond the traditional factors that estimate the risk of atherosclerotic disease.","PeriodicalId":93885,"journal":{"name":"Archivos de cardiologia de Mexico","volume":" ","pages":"191-202"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Late-onset multivalvular carcinoid heart disease. 晚期多瓣类癌性心脏病

Archivos de cardiologia de Mexico Pub Date : 2024-02-02 DOI: 10.24875/ACM.23000165

Kristian Rivera, Marta Zielonka, Tania Ramírez-Martínez, Nuria Pueyo-Balsells, Diego Fernández-Rodríguez

引用次数: 0